Daclatasvir Dihydrochloride and Hydrocodone Extended-Release Tablets
Determining the interaction of Daclatasvir Dihydrochloride and Hydrocodone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Daclatasvir Dihydrochloride-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Daclatasvir Dihydrochloride-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Daclatasvir Dihydrochloride-Hydrocortisone
- Daclatasvir Dihydrochloride-Hydrocortisone (Systemic)
- Daclatasvir Dihydrochloride-Hydrocortisone 2.5%
- Hydrocodone Extended-Release Tablets-Daclizumab
- Hydrocodone Extended-Release Tablets-Daclizumab Subcutaneous
- Hydrocodone Extended-Release Tablets-Dacogen
- Hydrocodone Extended-Release Tablets-Dacomitinib
- Hydrocodone Extended-Release Tablets-Dactinomycin
- Hydrocodone Extended-Release Tablets-Dactinomycin Injection